【2h】

Overexpression of the

机译:过度表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The development of oral squamous cell carcinoma (OSCC) is a multistep process that requires the accumulation of genetic alterations. To identify genes responsible for OSCC development, we performed high‐density single nucleotide polymorphism array analysis and genome‐wide gene expression profiling on OSCC tumors. These analyses indicated that the absent in melanoma 2 (AIM2) gene and the interferon‐inducible gene 16 (IFI16) mapped to the hematopoietic interferon‐inducible nuclear proteins. The 200‐amino‐acid repeat gene cluster in the amplified region of chromosome 1q23 is overexpressed in OSCC. Both AIM2 and IFI16 are cytoplasmic double‐stranded DNA sensors for innate immunity and act as tumor suppressors in several human cancers. Knockdown of AIM2 or IFI16 in OSCC cells results in the suppression of cell growth and apoptosis, accompanied by the downregulation of nuclear factor kappa‐light‐chain‐enhancer of activated B cells activation. Because all OSCC cell lines have reduced p53 activity, wild‐type p53 was introduced in p53‐deficient OSCC cells. The expression of wild‐type p53 suppressed cell growth and induced apoptosis via suppression of nuclear factor kappa‐light‐chain‐enhancer of activated B cells activity. Finally, the co‐expression of AIM2 and IFI16 significantly enhanced cell growth in p53‐deficient cells; in contrast, the expression of AIM2 and/or IFI16 in cells bearing wild‐type p53 suppressed cell growth. Moreover, AIM2 and IFI16 synergistically enhanced nuclear factor kappa‐light‐chain‐enhancer of activated B cells signaling in p53‐deficient cells. Thus, expression of AIM2 and IFI16 may have oncogenic activities in the OSCC cells that have inactivated the p53 system. (Cancer Sci 2012; 103: 782–790)
机译:口腔鳞状细胞癌(OSCC)的发展是一种需要累积遗传改变的多步骤过程。为了鉴定负责OSCC开发的基因,我们在OSCC肿瘤上进行了高密度单核苷酸多态性阵列分析和基因组基因表达谱。这些分析表明,黑色素瘤2(AIM2)基因中的缺席和映射到造血干扰素诱导核蛋白的干扰素诱导基因16(IFI16)。染色体1Q23的扩增区域中的200氨基酸重复基因簇在OSCC中过表达。 AIM2和IFI16都是细胞质双链DNA传感器,用于先天免疫,并充当几种人类癌症中的肿瘤抑制剂。 OSCC细胞AIM2或IFI16的敲低导致细胞生长和凋亡,伴随着活化B细胞活化的核因子Kappa-Light-Enhancoger的下调。因为所有OSCC细胞系具有降低的P53活性,所以在P53缺陷的OSCC细胞中引入了野生型P53。野生型P53抑制细胞生长的表达及诱导凋亡抑制活化B细胞活性的核因子κ-轻链增强剂。最后,AIM2和IFI16的共表达显着增强了P53缺陷细胞中的细胞生长;相比之下,亚目目标2和/或IFI16在轴承野生型P53抑制细胞生长中的表达。此外,AIM2和IFI16协同增强的P53缺陷细胞中活化B细胞的核因子Kappa-Light-Chion-Enhancer。因此,AIM2和IFI16的表达可以在OSCC细胞中具有致癌P53系统的致癌活性。 (癌症SCI 2012; 103:782-790)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号